POPS RICHARD F
SEC Form 4 insider trading activity
POPS RICHARD F has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including NBIX, ALKS, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: May 21, 2026.
On the most recent filing, POPS RICHARD F is listed as Director at NEUROCRINE BIOSCIENCES INC. Inside the rolling window, POPS RICHARD F reported no open-market purchases and 1 open-market sale totaling $2.4M in NBIX.
Companies traded
Other insiders at NBIX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.4M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has POPS RICHARD F made?
POPS RICHARD F has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including NBIX, ALKS since 2026.
Which companies does POPS RICHARD F trade?
POPS RICHARD F has filed SEC Form 4 disclosures for 2 companies, including NBIX, ALKS.
When was POPS RICHARD F's most recent SEC Form 4 filing?
POPS RICHARD F's most recent SEC Form 4 filing on Tracefour is dated May 21, 2026.
What is POPS RICHARD F's total buy and sell value in the current window?
Inside the rolling retention window, POPS RICHARD F bought $0 and sold $2.4M based on SEC Form 4 filings.
What was POPS RICHARD F's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 NBIX shares on 2026-05-15, worth $2.4M, per SEC Form 4 filings.